Loading patent…
AssigneeNanosphere Health Sciences, LLC
InventorRichard Clark Kaufman
Estimating the term…
This disclosure teaches phospholipid nanoparticle compositions of cannabinoids formed from phospholipids and simpler lipids in an unfired sequential process that encapsulate a high concentration of cannabinoids, and create standardized precision-metered dosage forms of cannabinoids; yielding an increase cannabinoid transport across hydrophobic mucosa; increase the bioavailability of the cannabinoid 2-fold to 8-fold, decrease the dose of cannabinoids 2-fold to 8-fold less than an amount of cannabinoids needed to illicit the same therapeutic effect compared to raw and non-encapsulated cannabinoids; where the nanoparticle dynamic structure reduces the adverse effects of cannabinoids; and enable safe more efficacious cannabinoid therapy.
A nanosphere compositional structure comprising encapsulated cannabinoids dispersed into a stable adjustable fluid viscoelastic nanoparticle structure comprised of an outer single layer of essential phospholipids, liquid lipids and excipients;
-3 (canceled)
(canceled)
-15. (canceled)
A method of cannabinoid therapy comprising administering to a mammal a phospholipid nanoparticle composition of cannabinoids comprising single layer phospholipids and liquid lipids process that encapsulate a high concentration of cannabinoids and wherein the cannabinoids have therapeutic activity.
A method of cannabinoid therapy comprising treating a mammal with stable adjustable fluid viscoelastic lipid nanoparticle compositions of cannabinoids comprised of lipids and excipients that deliver standardized and precision-metered microliter dosages of cannabinoids.
Dependencies are inferred from the claim text.